AMYRIS, INC.
EMERYVILLE, CA

Amyris, Inc. is a pioneering industrial biotechnology company renowned for delivering renewable products that contribute to positive global change. Founded over a decade ago with the mission of leveraging science for a sustainable future, Amyris has developed innovative proprietary processes to convert plant-sourced sugars into renewable chemicals through highly engineered yeast organisms. This groundbreaking approach first materialized in producing a cost-effective and stable source of artemisinin—an essential anti-malarial drug—saving countless lives by stabilizing the treatment's accessibility and affordability for malaria affected regions. Amyris is distinguished as the only company that has successfully scaled and manufactured new products using these unique ingredients. The company continues to disrupt markets across several rapidly growing global industries, delivering high-performance solutions with a focus on bettering consumer experiences and supporting environmental health. Prominent achievements include development within their µPharm™ platform for biopharmaceutical applications and the launch of Biofene, Amyris’s sustainable farnesene-based product line boasting significant demand in cosmetics, fragrances, fuels, and nutraceuticals. The company thrives on intelligent risk-taking, innovation, and a culture that fosters creativity, collaboration, and sustainability. With headquarters located in Emeryville, California, and key operations based in Brazil through partnerships such as Aprinnova, Amyris's global footprint signifies its status as one of the fastest-growing entities in industrial biotechnology. The company is proud to have cultivated an internal environment of fun, teamwork, ethics, and accountability while offering competitive compensation packages and promoting wellness initiatives. Amyris continues expanding into new sectors including sustainable beauty through Biossance brand, flavors & fragrances business catering major global brands, and health-oriented food ingredients aiming at enhanced consumer well-being. With a commitment to shorter product development cycles, Amyris empowers partners to expedite market entry while capturing significant market share. Officially incorporated in Florida with status as an active entity post recent developments including filing adjustments in 2025, Amyris maintains transparency and ethical governance under leadership comprising CFO Han Kieftenbeld, Director John Doerr, and Director Geoffrey Duyk. To learn more about their endeavors, visit their official website at amyris.com.